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ABSTRACT 
 
         The extract of   Chloroxylon sweitenia (Family: Rutaceae) leaves  were investigated for 
its anti-inflammatory  activity at the different doses in the standard animal models. The 
experimental paradigms used were carrageenan induced rat paw oedema (acute), and cotton 
pellet induced granuloma (chronic) models in rats for anti-inflammatory activity.  In rats the 
toxicity was also performed for the extract by oral administration. The chloroform extract of 
Chloroxylon sweitenia (CECS) exhibited significant anti-inflammatory effect at the dose 50, 
100 and 200 mg/kg.  Maximum inhibition (55.32  %) was noted at the dose of 200 mg/kg
 after 
3 h of drug treatment in carrageenan induced paw oedema, whereas the Diclofenac (standard 
drug) produced 61.33 % of inhibition.  In the chronic model (cotton pellet induced granuloma) 
the CECS (200 mg/kg) and standard drug showed decreased formation of granuloma tissue by 
52.32 % and 56.32 % (p < 0.001) respectively. The CECS further evaluated for their toxicity 
effect at the doses of 100 mg/kg administered for 14 days to orally in rats. At the end of 
experiments the blood, liver function and kidney metabolism was observed. The effect of 
CECS was assessed by the change in the body weight, lipid peroxidation and glutathione 
content (GSH) activities were measured from hepatic tissues. The hematological profile and 
different biochemical parameters such as SGOT, SGPT, and ALP were also estimated. Thus, 
the present study revealed that the chloroform extract of Chloroxylon sweitenia exhibited 
significant anti-inflammatory activity in the tested models Toxicity study indicates that the 
extract is non-toxic at the tested doses. 
 
Key words: Chloroxylon sweitenia, carrageenan, cotton pellet induced granuloma, anti-
inflammatory activity. 
 
INTRODUCTION 
 
Inflammation is a natural response of the 
mammalian body to a variety of hostile 
agents including parasites, pathogenic 
microorganism, toxic chemical substance 
and physical damage to tissue.   
Inflammation or phlogosis is a 
pathophysiological response of living tissue 
to injuries that leads to the local 
accumulation of plasmatic fluid and blood 
cells. The inflammatory process is 
invariably characterized by a production of 
prostaglandins, leukotrienes, 
histamine,bradykinin, platelet-activating 
factor (PAF) and by a release of chemicals 
from tissues and migrating cells 
1).  
Carrageenan-induced local inflammation is 
Pages 33 - 43  2
commonly used to evaluate non-steroidal 
anti-inflammatory drugs (NSAID). It 
appears that the onset of the carrageenan 
local inflammation has been linked to 
neutrophil infiltration and the production of 
neutrophil-derived free radicals, such as 
hydrogen peroxide, superoxide and 
hydroxyl radical, as well as to the release of 
other neutrophil-derived mediators
2). In 
particular, the initial phase of inflammation 
(oedema, 0–1 h) which is not inhibited by 
NSAID such as Diclofenac or aspirin, has 
been attributed to the release of histamine, 
5-hydroxytryptamine and bradykinin, 
followed by a late phase (1–6 h) mainly 
sustained by prostaglandin release and more 
recently has been attributed to the induction 
of inducible cyclo-oxygenase (COX-2) in 
the tissue
3).  
 
The continued search for potential effective   
and safe anti-inflammatory agents cannot 
be over-emphasized. This is important, in 
view of the roles played by the 
inflammatory process and inflammatory 
mediators in diseases such as asthma, 
rheumatoid arthritis, cancer and 
neurodegenerative disorders.  Chloroxylon 
swietenia DC (East Indian satin wood) is a 
moderate size tree common in dry 
deciduous forests throughout Indian 
peninsula and in Ceylon
4). Stem bark 
pounded and the juice applied for 
ophthalmic infection and cataract by 
Malayalis. Various parts of the plant are 
traditionally used in rheumatism and the 
leaves are applied to wounds
5). This species 
has been extensively investigated and a 
number of chemical constituents from the 
leaves, bark and roots of the plant have 
previously reported in a number of 
instances which includes alkaloids
6-7), 
cumarin 
8-9), lignans
10). However, no work 
has been reported on the anti-inflammatory 
effects on acute and chronic phases of 
inflammation, C. sweitenia. Keeping this in 
view, the present study has been 
undertaken to investigate the anti-
inflammatory and toxicity studies of 
chloroform extract of C. sweitenia (CECS) 
in standard animal models. 
 
MATERIALS AND METHODS 
 
Plant Material  
 
The plants Chloroxylon sweitenia  were 
collected in the month April 2004 from the 
Komarapalayam, Namakkal district, 
Tamilnadu, India. The plant material was 
taxonomically identified by the Botanical 
survey of India, Coimbatore, Tamilnadu 
and the voucher specimen SK-7 was 
retained in our laboratory for future 
reference. The leaves of each of the plant 
material were dried under shade and then 
powdered with a mechanical grinder. The 
powder was passed through sieve no 40 and 
stored in an airtight container for further 
use. 
 
Chemicals and Reagents 
 
The chemicals used in the present study 
were carrageenan (S. D. Fine Chemicals 
Limited, Bombay), and Diclofenac sodium  
(Torrent, Bombay). 
 
Preparation of Extract 
 
The dried powdered plant material was 
extracted with chloroform in a Soxhlet 
extraction apparatus.  The solvent was 
removed under reduced pressure and semi 
solid mass was obtained (yield 7.75 %). 
The extract showed positive test for 
alkaloids, steroids, and tannins. The extract 
at the different doses of 50, 100 and 200 
mg/kg was suspended in aqueous Tween 80 
solution (2 %) and Diclofenac (10 mg/kg) 
in saline were used for the present study. 
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Animals 
 
Swiss albino mice of either sex weighing 
between (18-22 g) or Albino Wistar rats of 
the either sex (180-200 g) were used for the 
present study. They were maintained under 
standard environmental conditions and 
were fed with standard pellet diet with 
water ad libitum. 
 
Investigation of Anti-inflammatory 
effects by Carragenan Induced Paw 
odema  
 
The rats were divided into 5 groups (n = 6). 
The extract and the standard used for this 
study were prepared in the same manner as 
mentioned earlier. Animals were deprived 
of food and water for 18 hours before the 
experiment. On the day of the experiment 
they were assigned to 5 groups of six 
animals each. They were marked and 
numbered for identification. Paw oedema 
was induced by subplantar injection into 
the rat right hind paw of 0.1 ml sterile 
saline containing 1% carrageenan (control 
group). A group of rats were treated with 
test compounds and standard drugs were 
administered orally concomitantly with 
carrageenan injection. Control group of 
animals received the same volume of 
vehicle instead of the tested agents. The 
volume of the paw was measured by a 
plethysmometer immediately after the 
injection as previously described
11-12). 
Subsequent readings of the same paw were 
carried out at one-hour intervals up to 4 h 
and compared to the initial readings. The 
increase in paw volume was taken as 
oedema volume. The percentage of 
inhibition of inflammation was calculated 
for comparison.  
 
The ratio of the anti-inflammatory 
effect of CECS was calculated by the 
following equation: anti-inflammatory 
activity (%) = (1-D/C) x 100, where D 
represents the percentage difference in 
paw volume after CECS was 
administered to the rats, and C 
represents the percentage difference of 
volume in the control groups.  
 
Cotton pellets-induced granuloma    
 
The rats were divided into five groups 
(n = 6). The cotton pellet granuloma 
model investigated the proliferation 
phase of inflammation
13).  The extract 
of different doses (50,100 and 200 
mg/kg) and Diclofenac at 10 mg/kg 
body weight was given to the animals 
orally. After 30 min the animals were 
anesthetized. After shaving the fur, the 
rats were anaesthetized and 10 mg of 
sterile cotton pellets were inserted, one 
in each axilla. The extracts was 
administered daily for a period of seven 
days. The rats were sacrificed after   a 
high dose of anesthesia on the eighth 
day and the pellets were removed 
surgically and made free from 
extraneous tissues. The pellets were 
incubated at 37° C for 24 h and dried at 
60° C to constant weight. Increment in 
the dry weight of the pellets was taken 
as measure of granuloma formation. 
 
Short term toxicity study 
 
The extract administrated at the doses 
of 50 and 200 mg/kg orally once daily 
and it was continued upto 14 days to 
observe any short-term toxicity. Then, 
at the end of experiments the 
hematological  profile and different 
biochemical parameters of hepatorenal 
function were observed. 
 
Blood collected and hematological 
parameters were determined as 
described in hematological studies 
14). 
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Liver and other important internal 
organs were removed, weighed and 
observed for pathological changes.    
 
The blood was centrifuged at 3000 rpm 
at 4°C for 10 minutes to separate serum. 
The activities of   serum glutamate 
oxaloactetate transaminase level 
(SGOT) and serum glutamate pyruvate 
transaminase (SGPT) were assayed by 
method 
14) . The alkaline phosphatase 
activity in the serum was measured 
according to the procedure of King   
(1965a) method by 
spectrophotometrically
15). Further, liver 
biochemical parameters were estimated 
by methods described in estimation of 
biochemical parameters. 
 
Biochemical assays and hematological 
studies  
 
Hemoglobin content, leucocytes counts, 
mean corpuscular volume (MCV) and 
mean corpuscular hemoglobin 
concentration (MCHC) were 
determined by standard methods
16) 
.Blood urea was determined by the 
diacetyl monoxime method of Leclerc 
and Schwarz (1957). Hemoglobin 
content 
18) was estimated from the 
peripheral blood of normal, control and 
treated animal groups. Protein content 
was measured by the method of Lowry 
et al. (1951) using bovine serum 
albumin (BSA) as the standard
17). 
 
The liver was excised, rinsed in ice-
cold normal saline followed by cold 
0.15 M Tris-HCl (pH 7.4), blotted and 
weighed. The homogenate was 
processed for estimation of  lipid 
peroxidation and GSH. Assay for 
microsomal lipid peroxidation was 
carried out by the measurement of 
thiobarbituric acid reactive substances 
(TBARS) in the tissues reported 
19) by 
Ohkawa  et al., 1979. The pink 
chromogen produced by the reaction of 
malondialdehyde, which is a secondary 
product of lipid peroxidation reaction 
with thiobarbituric acid was estimated 
at 532 nm.  Reduced glutathione (GSH) 
in the tissues was assayed by the 
method of Ellman 
20)  (1979). GSH 
estimation is based on the development 
of yellow color when 5,5’-dithiobis (2-
nitro benzoic acid) di-nitrobisbenzoic 
acid was added to compounds 
containing sulphydryl group.    
 
Statistical Analysis 
 
  The results are expressed as mean ± 
SEM. The statistical analysis was 
performed by ANOVA test. 
RESULT  
 The chloroform extract of leaves part 
of Chloroxylon sweitenia was evaluated 
for anti-inflammatory activity in acute 
and chronic experimental animal 
models and the results are summarized 
in table 1, 2,3 and 4. As shown in table 
1, the chloroform extract showed 
inhibition of 39.07, 44.90, 55.32 % at 
the doses of 50, 100 and 200 mg/kg
 
after 3 h of drug treatment in 
carrageenan induced paw oedema, 
whereas the standard drug showed 
61.33 % of inhibition.  As shown in 
table 3, in the chronic model (cotton 
pellet induced granuloma), of the 
different doses of the CECS and 
standard drug showed decreased 
formation of granuloma tissue at     
28.48, 41.13, 52.32 % and 56.32 % (p 
< 0.001), respectively. The 
heamatological profile and biochemical 
parameter were shown in table 
4.Hematological parameters like 
hemoglobin remained unaltered at the 
Pages 33 - 43  5
dose of 50 and 200 mg/kg. The 
hematological parameters such as urea, 
transaminase activities increased at the 
dose of 200 mg/kg. A comparison of 
activities of the lipid peroxidation, GSH 
and the levels of SGOT, SGPT and 
associated biochemical parameter for 
the study were compared with 
corresponding values in a normal, 
control and standard shown in table 3 
and 4.    
DISCUSSION  
The potential of the CECS for its anti-
inflammatory effect and short-term toxicity 
was investigated. The effect of CECS at the 
dose of 50,100 and 200 mg/kg showed 
significant anti-inflammatory activity. 
Significant anti-inflammatory activity was 
observed for CECS in carrageenan-induced 
oedema and also the chronic models.  
The present study establishes the anti-
inflammatory activity of chloroform extract 
of Chloroxylon sweitenia.  It is evident that 
carrageenan is a sulphated polysaccharide 
obtained from sea weed (Rhodophyceae) 
and is commonly used to induce acute 
inflammation and is believe to be bi-phasic. 
The first phase is due to release of 
histamine and serotonin. The second phase 
is caused by the release of bradykinin, 
protease, prostaglandin and lysosome 
21) . It 
has been reported that second phase of 
edema is sensitive to most clinically 
effective anti-inflammatory drugs, which 
has been frequently used to access the anti-
edematous effect of natural products
.22-23).
  Prostaglandins play a major role in 
the development of second phase of 
reaction that is measured at 3 hours time. 
These mediators take part in the 
inflammatory response and are able to 
stimulate nociceptor and thus induce pain 
24).  It is also the   prostaglandin amplifies 
the pain mechanism and enhances vascular 
permeability whilst the leukotrienes 
contract smooth muscles blood vessels.     
And it leads to enhance the vascular 
permeability and mediate proinflammatory 
and allergic response
25-26).  Diclofenac is a 
potent onhibitor of prostaglandin formation 
and thereby reduces inflammation and 
arthritic pain. Furthermore, diclofenac has 
been reported to reduce chemotaxis oxygen 
derived free radical generation and neutral 
production 
36).    Based on these reports, it 
can be inferred that the inhibitory effect of 
the extract of Chloroxylon sweitenia  on 
carrageenin-induced inflammation in rats 
may by due to inhibition of the mediators 
responsible for inflammation.  
Chronic inflammation is a reaction arising 
when the acute response is in sufficient to 
eliminate proinflammatory agents. Chronic 
inflammation includes a proliferation of 
fibroblasts and the infiltration of 
neutrophills and exudation. The cotton 
pellet granuloma widely used to evaluate 
the transudative and proliferative 
components of the chronic inflammation. 
The moist weight of the pellets correlates 
with transuda, the dry weight of the pellet 
of the correlates with the amount of 
granulumatous tissues
27-28) Chronic 
inflammation occurs by means of the 
development of proliferate cells. These 
cells can be either spread or in granuloma 
form. Non-steroidal anti-inflammatory 
drugs decrease the size of granuloma which 
results from cellular reaction by inhibiting 
granulocyte infiltration/inflammation, 
preventing   generation of collagen fibers 
and suppressing mucopolysaccharides
29-30). 
This result indicates the efficacy of the 
extract, which possesses anti-inflammatory 
activity. 
Serum transaminase elevation has been 
reported to be associated with a number of 
inflammatory disorders and hepatocelluar 
damage
.  Leakage of large quantities of 
enzymes into the blood stream is often 
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associated with massive necrosis of the 
liver.   Serum enzymes elevation has also 
been reported to be associated with number 
of inflammatory disorders 
31)  .It is also 
reported that the low heamoglobin 
concentration 
32) with increased level of 
serum alkaline phosphatase 
38) and serum 
creatinine
34) are noted in chronic 
inflammatory disease such as rheumatoid 
arthritis, which is usually associated with 
anorexia and weight loss.  Also, methyl 
prednisolone was reported that the level of 
serum protein content is lowered in 
rheumatoid arthritis in human
35).  The 
present study revealed that CECS is non-
toxic at the tested doses and also indicates 
that for the safety use of the extract.  
  
From the above discussion, the extract 
exhibited significant anti-inflammatory 
activity and did not affect the 
heamatological and biochemical profiles of 
hepato-renal function. Thus this study 
substantiates the use of this plant as an anti-
inflammation folklore medicine. Further 
detailed investigation is underway to 
determine the exact phytoconstituents 
responsible for the anti-inflammatory 
activity. 
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Table 1. Effect of the Chloroxylon  sweitenia  extract on carrageenan and 
induced pedal oedema 
 
Treatment  Dose 
(mg/kg) 
Paw volume 
(ml) 
Percentage of 
inhibition 
 
Carrageenan control 
 
0 
 
0.732 ± 0.063 
 
- 
 
Diclofenac  12.5  0.283 ± 0.024  61.33  
 
CECS  50  0.446 ± 0.035  39.07  
 
CECS   100  0.403 ± 0.028  44.90  
 
CECS   200  0.327 ± 0.017  55.32  
 
 
Values are mean ± SEM (n = 6). Experimental groups were compared with control p < 0.001. 
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Table 2. Effect of the Chloroxylon  sweitenia extract on cotton-pellets 
Induced granuloma in rats 
 
 
Treatment 
 
Dose 
(mg/kg) 
 
Weight of cotton 
pellet 
(mg) 
 
Percentage of 
inhibition 
 
Control  
 
0 
 
47.4 ± 4.12 
 
 
- 
 
Diclofenac  12.5  20.7 ± 1.82  56.32  
 
CECS   50  33.9 ± 2.43  28.48  
 
CECS   100  27.9 ± 1.70  41.13  
 
CECS   200  22.6 ± 2.2  52.32 
 
 
Values are mean ± SEM (n = 6). Experimental groups were compared with control p < 0.001. 
 
Table-3. Effect of  Chloroxylon  sweitenia  extract on hematological and 
different biochemical parameters in rats 
 
Experimental 
 
 
 
S.No
. 
 
 
Parameters  Control 
(Normal 
saline 
5 ml /kg ) 
  CECS 
(50 mg/kg) 
CECS 
(200 mg/kg) 
Diclofenac 
(12.5 mg /kg) 
 
 
 
1 
 
Hemoglobin (g %) 
 
12.4 ± 1.10 
   
12.5 ± 0.83 
 
12.3 ± 1.04 
 
12.4 ± 1.21 
 
2 
 
Haematocrit % 
 
37.7 ±1.94 
   
37.7 ± 1.43 
 
35.7 ± 1.23
 b 
 
36.9 ± 1.24 
 
3 MCHC  % 
 
 
33.4 ± 2.83    33.2 ± 2.17  32.4 ± 0.77  33.5 ± 0.71 
4  MPV  134.8 ± 7.36    132.4 ± 3.31
 b  138.6 ± 4.65
a  141 ± 3.72
 b 
 
5 Platelets 
(10
3x mm
3)
     
 
1358 ± 41.2    1355.0 ±74.1  1346 ± 57.13
 a  1257.4 ± 42.2 
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  Liver and Kidney 
function test 
       
6    114.9 ± 8.57    114.8 ± 6.44
 a  110.5 ± 1.62
   98.8 ± 1.34
 a 
7 SGOT  (U/L) 
 
20.7± 1.72    20.1 ± 2.21
 b  19.5 ± 1.74
   19.7 ± 1.88 
8 SGPT(U/L) 
 
60.2 ± 3.04    59.9 ± 4.8
 b  67.4 ± 4.65  43.7± 3.95
 b 
9 ALP  (U/L) 
 
0.38 ± 0.02    0.39 ± 0.02  0.48 ± 0.03  0.45 ± 0.02
 a 
 
10 Creatinine  (mg/dl) 
 
18.4 ± 0.87    16.5 ± 1.48  21.5 ± 1.74
  17.6  ±1.29
 a  
 
11  BUN (mg/dl)  7.2 ± 0.04    7.23 ± 0.65  6.92 ± 0.53  6.85 ± 0.54 
 
Protein (g/dl) 
 
Values are mean ± SEM (n=6).  Groups was compared with normal control group 
a p< 0.001, 
b 
p< 0.01 
 
Table.4. Effect of Chloroxylon sweitenia extract on Lipid peroxidation and 
Glutathione status in rats 
 
Experimental 
 
 
 
S.No. 
 
 
Parameters  Control 
(Normal 
saline 
5 ml /kg ) 
  CECS 
(50 mg/kg) 
CECS 
(200 mg/kg) 
Diclofenac 
(12.5 mg /kg) 
 
 
 
1. 
 
Lipid 
peroxidation 
 
0.97 ± 0.060 
   
0.98 ± 0.84 
 
1.17 ± 1.04 
 
1.13 ± 1.21 
 
2. 
 
Reduced 
Glutathione 
 
2.37 ±1.94 
   
2.38 ± 1.43 
 
2.52 ± 1.23
 b 
 
2.47 ± 1.24 
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